Fibrinolysin consists of two polypeptide chains, one light and one heavy, linked by a disulfide bond. The light chain has a molecular weight of approximately 27,000 Da and contains the... Fibrinolysin is used as a local healing ointment when combined together with the enzyme deoxyribonuclease I (extracted from bovine pancreas).
- Mechanism
- Curator reviewed
Fibrinolysin attacks and inactivates fibrin molecules occurring in undesirable exudates on the surface of the human body and on human mucosa, e.g., in superficial wounds and burns, while desoxyribonuclease targets and destroys (human) DNA. The combination of the two enzymes has a synergistic effect on necrotic but not on living tissue.
- Primary indication
- Fibrinolysin assists with the healing of minor burns, superficial wounds, ulcers, surgical wounds, and superficial hematomas.Curator reviewed
- Formula / weight
- C3848H5912N1096O1185S60 · 88411.4 Da
- Also known as
- Bovine Fibrinolysin · Bovine Plasmin · Fibrinolysin (human) · Fibrinolysin, human · plasmin
Resolves to
What you can answer from here — as of November 19, 2025
Which drugs share a target with Fibrinolysin, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account